戻る
Hua Medicine (Shanghai) Ltd. (02552.HK)価格
02552.HK 株価推移チャート
HUA MEDICINE-B (02552.HK)
Hua Medicine (Shanghai) Ltd.
HK$3.25
-4.69%
$-0.16
休場: Jan 16, 16:00:00 HKT
データなしEarnings FAQ
02552.HKの最近の1株当たり利益（EPS）は予想と比較してどうでしたか？
Hua Medicine (Shanghai) Ltd. 02552.HKの前四半期の収益はどうでしたか？
Hua Medicine (Shanghai) Ltd.の収益見積もりはいくらですか？
Hua Medicine (Shanghai) Ltd.の収益品質スコアはどれくらいですか？
Hua Medicine (Shanghai) Ltd.はいつ収益を報告しますか？
Hua Medicine (Shanghai) Ltd.の予想収益はいくらですか？
Hua Medicine (Shanghai) Ltd.は収益予想を上回りましたか？
主要データ
前終値
$3.41
始値
$3.41
当日レンジ
$3.2 - $3.41
52週レンジ
$1.24 - $4.95
取引高
5.3M
平均取引高
3.5M
1株当たり利益(TTM)
1.21
配当利回り
--
時価総額
$3.2B
HUA MEDICINE-Bとは何ですか？
Hua Medicine Ltd. provides drug discovery and development services. The company is headquartered in Shanghai, Shanghai and currently employs 285 full-time employees. The company went IPO on 2018-09-14. The firm is also engaged in the commercialization of HuaTangNing products. The Company’s main product pipeline dorzagliatin or HMS5552 is a glucokinase activator or GKA, designed to control the progressive degenerative nature of diabetes by restoring glucose homeostasis in Type 2 diabetes. The firm mainly conducts its business in the domestic market.